Search
Search
Close this search box.

Ohio’s Adult-Use Cannabis Market Hits $143m in Sales Since Launch

Ohio’s adult-use cannabis sales have now topped $140m since the retail market launched in earnest in August, according to the latest figures from Ohio Department of Commerce’s Division of Cannabis Control.

Between the launch of the market on August 06 and November 02, ‘non-medical’ cannabis sales hit $143.4m, including 17,911 pounds of cannabis flower and 2,285,636 units of manufactured products.

Over the period, revenue growth has been consistent, seeing a steady increase between September and October following an initial surge in August.

By the end of September, total non-medical sales reached $87.1m, with sales of 10,213 pounds of flower and 1.36m units of manufactured products. October ended with $131.8m in cumulative sales​, seeing an average of $47m per month.

Since the launch of Ohio’s adult-use cannabis, prices for both non-medical and medical cannabis have shown a gradual decline.

When adult-use sales began, recreational flower averaged $26.59 per 1/10 oz (about $9.40 per gram), while manufactured products like edibles and concentrates averaged $31.06 per unit.

By early November, these prices had decreased to $21.49 per 1/10 oz (around $7.59 per gram) for flower and $29.01 per unit for manufactured products. This downward trend likely reflects a response to strong initial demand and a gradually balancing supply chain.

Similarly, medical cannabis prices have followed a comparable pattern, showing incremental declines. Medical flower prices began at approximately $22.21 per 1/10 oz ($7.85 per gram) in August but had dropped to $21.71 per 1/10 oz ($7.67 per gram) by late October.

Manufactured products in the medical market have remained somewhat steadier, averaging around $29.46 per unit in August and moving to $29.21 per unit by November.

Ohio currently has 124 dispensaries licensed to sell both medical and recreational cannabis. Despite the widespread availability, more than 100 cities and townships have enacted moratoriums blocking the sale of recreational cannabis as of October 22. While some moratoriums will expire later this year or next, others remain indefinite.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?